Challenges and countermeasures of Investigator-Initiated Trial of oncology / 中华医学科研管理杂志
Chinese Journal of Medical Science Research Management
; (4): 7-12, 2023.
Article
in Zh
| WPRIM
| ID: wpr-995820
Responsible library:
WPRO
ABSTRACT
Objective:
In order to put forward relevant measures and suggestions to improve the quality of the Investigator-Initiated Trials of oncology in medical institutions.Methods:
Through literature research, comparative study, combined with the implementation and management of investigator initiated trials, the current status and challenges of the administration of these trials were analyzed.Results:
Investigator-Initiated Trials of oncology become increasingly important. However, its quality is poor compared with Industry-Sponsored Trials due to insufficient funds and lack of effective supervision. Besides, four main challenges as follows were identified lack of clinical research professionals, the quality concerns of ethical review in some institutions, insufficient funding for clinical research, and imperfect quality management system.Conclusions:
Based on the actual needs of IITs of oncology, medical institutions should strengthen the talent cultivation, establish electronic information management platform, increase project support, strengthen scientific research supervision and deepen the awareness of risk prevention to improve the quality of investigator initiated trials.
Full text:
1
Index:
WPRIM
Language:
Zh
Journal:
Chinese Journal of Medical Science Research Management
Year:
2023
Type:
Article